The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
The FDA approved Zepbound (tirzepatide ... “This is the first drug treatment for obstructive sleep apnea, and so that’s exciting, and it provides a good opportunity to help the care of ...
This week, the Food and Drug Administration (FDA) announced that food companies in the U.S. have until January 15, 2027 to rid their products of Red Dye No. 3. (Drug manufacturers, meanwhile, have ...
The FDA banned the use of red dye No. 3 in foods and medicines sold in the U.S. because it has been shown to cause cancer in ...
The proposed "Nutrition info box" would show customers whether products have low, medium or high levels of saturated fat, ...
Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
Mesoblast winning approval for its Ryoncil ... having been knocked around by the FDA’s 2020 rejection of Ryoncil, requiring it to resubmit the drug. In August 2023 the company copped another ...
The key lies in adopting proven strategies that focus on sustainable lifestyle changes rather than quick fixes. A well-balanced diet combined with regular exercise and stress management are essential ...
The Food and Drug Administration (FDA) gave the green light ... in combination with a reduced-calorie diet and increased physical activity. “Today’s approval marks the first drug treatment ...